Stay updated on ELVN-001 for CML Treatment Clinical Trial
Sign up to get notified when there's something new on the ELVN-001 for CML Treatment Clinical Trial page.

Latest updates to the ELVN-001 for CML Treatment Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check8 days agoChange DetectedA site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology across NIH content.SummaryDifference1%

- Check15 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changes from v3.7.1 to v3.7.2, while the page continues to display a 403 error.SummaryDifference0.2%

- Check22 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check36 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the previous study details with a blocked access message. This indicates that the trial information on this page is not currently viewable by users.SummaryDifference20%

- Check43 days agoChange DetectedUI copy now shows 'Find contact information' and the revision tag was updated to v3.7.0, replacing the former 'Find Contact Information' label. This indicates a minor text/style update in the study page navigation and versioning.SummaryDifference0.1%

Stay in the know with updates to ELVN-001 for CML Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ELVN-001 for CML Treatment Clinical Trial page.